KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Revenue (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Revenue data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Revenue rose 14.28% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $4.3 billion, up 10.42%, while the annual FY2025 figure was $4.3 billion, 10.42% up from the prior year.
  • Revenue reached $1.1 billion in Q4 2025 per IDXX's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Revenue topped out at $1.1 billion in Q2 2025 and bottomed at $777.7 million in Q1 2021.
  • Average Revenue over 5 years is $922.2 million, with a median of $908.6 million recorded in 2023.
  • Peak YoY movement for Revenue: skyrocketed 6623.84% in 2021, then rose 3.43% in 2022.
  • A 5-year view of Revenue shows it stood at $801.1 million in 2021, then rose by 3.43% to $828.6 million in 2022, then rose by 8.81% to $901.6 million in 2023, then grew by 5.84% to $954.3 million in 2024, then rose by 14.28% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.